Primary Efficacy Analysis Demonstrates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Primary Efficacy Analysis Demonstrates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Primary Efficacy Analysis Demonstrates Today - Breaking & Trending Today

AMGEN ANNOUNCES POSITIVE TOP-LINE RESULTS FROM PHASE 3 STUDY OF ABP 654, BIOSIMILAR CANDIDATE TO STELARA® (USTEKINUMAB)

Published: April 18, 2022

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced preliminary results from a Phase 3 study evaluating the efficacy and safety of ABP 654 compared to STELARA®...

Source: prnewswire.com

Related Topics:

United StatesPuerto RicoMichael StrapazonJessica AkopyanKelley DavenportDavidm ReeseKyowa Kirin Co LtdDrug AdministrationBeigene LtdExchange CommissionTherapeutics IncEuropean UnionNational Psoriasis FoundationTeneobio IncPrimary Efficacy Analysis DemonstratesClinically Meaningful Differences ComparedClinical StudyUnited States LicensedDow Jones Industrial AverageBest WorkplacesGreat PlaceFive Prime TherapeuticsThousand OaksAccessed SeptemberBiotechnology